Frontlight ResearchEarly access
Triple-negative breast cancer trials in United Kingdom
26 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peoplePlatinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
- Where
- Ayr, Basingstoke, Bedford, Bournemouth, Bristol, Burton-on-Trent, Bury St Edmunds, Cambridge, Cardiff, Colchester, Dudley, Huntingdon, Ipswich, Kidderminster, Kilmarnock, London, Manchester, Northwood, Nottingham, Oxford, Peterborough, Poole, Redditch, Romford, Southampton, Swansea, Wakefield, Winchester, Worcester
- Age
- 16 years to 70 years
- People
- 780
- Run by
- Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT03150576